The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

January 2010

Volume 50, Issue 1

Pages 6–118

  1. Editorial

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
  2. Review

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
  3. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
    1. Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist (pages 27–35)

      Dr Wendell S. Akers, Dr Jennifer J. Oh, Dr Julie H. Oestreich, Dr Suellen Ferraris, Ms Mary Wethington and Dr Steven R. Steinhubl

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009344986

  4. Pharmacokinetics

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
    1. Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease (pages 36–49)

      Dr Jean-Francois Marier, Dr Mohamad-Samer Mouksassi, Dr Nathalie H. Gosselin, Dr Martin Beliveau, Dr Jane Cyran and Mr John Wallens

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009342252

    2. Systemic Bioavailability of Topical Diclofenac Sodium Gel 1% Versus Oral Diclofenac Sodium in Healthy Volunteers (pages 50–61)

      Dr Jean-Luc Kienzler, Dr Morris Gold and Mr Fabrice Nollevaux

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009336234

    3. Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure (pages 62–72)

      Ms Yuyan Jin, Dr Bruce G. Pollock, Dr Ellen Frank, Dr Giovanni B. Cassano, Dr Paola Rucci, Dr Daniel J. Müller, Dr James L. Kennedy, Dr Rocco Nicola Forgione, Ms Margaret Kirshner, Ms Gail Kepple, Dr Andrea Fagiolini, David J. Kupfer and Dr Robert R. Bies

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009337946

    4. Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking (pages 73–80)

      Ms Yuyan Jin, Dr Bruce G. Pollock, Dr Kim Coley, Dr Del Miller, Dr Stephen R. Marder, Dr Jeff Florian, Dr Lon Schneider, Dr Jeffrey Lieberman, Ms Margaret Kirshner and Dr Robert R. Bies

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009343694

  5. Pharmacodynamics

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
    1. The Safety of H2-Blockers Use During Pregnancy (pages 81–87)

      Dr Ilan Matok, Dr Rafael Gorodischer, Dr Gideon Koren, Dr Eyal Sheiner, Dr Arnon Wiznitzer, Dr Elia Uziel and Dr Amalia Levy

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009350483

    2. Effect of Thyroid Hormone on the Activity of CYP3A Enzyme in Humans (pages 88–93)

      Dr Norio Takahashi, Dr Naoki Inui, Dr Hiroshi Morita, Dr Kazuhiko Takeuchi, Dr Shinya Uchida, Dr Hiroshi Watanabe and Dr Hirotoshi Nakamura

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009344336

    3. A Randomized, Placebo-Controlled Study of the Effects of the p38 MAPK Inhibitor SB-681323 on Blood Biomarkers of Inflammation in COPD Patients (pages 94–100)

      Dr Dave Singh, Dr Lucy Smyth, Dr Zoe Borrill, Dr Lisa Sweeney and Dr Ruth Tal-Singer

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009347873

  6. Drug Interactions

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
    1. Effect of Telithromycin on the Pharmacokinetics and Pharmacodynamics of Oral Oxycodone (pages 101–108)

      Dr Juha Grönlund, Dr Teijo Saari, Dr Nora Hagelberg, Dr Ilkka K. Martikainen, Dr Pertti J. Neuvonen, Dr Klaus T. Olkkola and Dr Kari Laine

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009336444

  7. Brief Report

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology
    1. Estimating the Contribution of Genes to Variation in Renal Drug Clearance by Active Secretion Using Multiple Data From Clinical Phase I Studies (pages 109–114)

      Dr Tomoe Fujita, Dr Yuji Kumagai, Ms Ichimi Nakahara, Dr Yoshio Ohtani and Dr Masataka Majima

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009348502

  8. American College of Clinical Pharmacology

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Drug Interactions
    8. Brief Report
    9. American College of Clinical Pharmacology

SEARCH

SEARCH BY CITATION